The NIH-Moderna Vaccine: Public Science, Private Profit, and Lessons for the Future

Authors

Christopher J. Morten, Columbia Law SchoolFollow

Document Type

Article

Publication Date

2023

DOI

https://doi.org/10.1017/jme.2023.149

Abstract

This commentary highlights the scientific history of the NIH-Moderna COVID-19 vaccine and corroborates Sarpatwari’s theme of private capture of value created by the public. The commentary also identifies missteps by the Trump and Biden Administrations and offers policy recommendations: better contracts with and incentives for pharmaceutical manufacturers and a not-for-profit “public option” for pharmaceutical development.

Disciplines

Law | Medical Jurisprudence | Pharmacy and Pharmaceutical Sciences | Public Health

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Christopher J. Morten, The NIH-Moderna Vaccine: Public Science, Private Profit, and Lessons for the Future, 51(S2) J. L. Med. & Ethics 35 (2023).
Available at: https://scholarship.law.columbia.edu/faculty_scholarship/4426